Join a panel of leading experts from biotech, pharma, and the investor community as they share cutting-edge approaches and discuss how the convergence of technology is accelerating the path from discovery to treatment. The discussion will cover:

• Neuroinflammation: Understanding and targeting the immune system’s role in neurodegenerative diseases.
• Gene and cell therapies: Exploring transformative approaches to modify or replace genes and cells responsible for CNS disorders.
• Biomarkers: Identifying new ways to diagnose and monitor disease progression with greater precision.
• Digital therapeutics: Leveraging technology to provide non-pharmacological interventions and enhance patient care.
• Technological convergence: How AI, big data, and other deep tech are unlocking novel biological insights and streamlining R&D.

This session offers a deep dive into the challenges and opportunities in the CNS landscape, providing a forward-looking perspective on the innovative strategies paving the way for a new era of brain health.